Vertex Pharmaceuticals
Executive Summary
Jerome Groopman, MD, to scientific advisory board. Groopman is New England Deaconess Hospital Hematalogy/Oncology Division chief and an associate professor at Harvard Medical School. He also is chairman of FDA's Biological Response Modifiers Advisory Committee, and he serves on the board of directors of the American Foundation for AIDS Research. An authority on AIDS and retroviral infection, Groopman is expected to advise the Cambridge, MA-based start-up firm on their anti-viral projects.